← Leaderboards
Carlos Fernandez-Del Castillo
Sloan-Kettering Inst Can Research
$656,600
Attributed
$1,969,801
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $493.4K · FY2014–18$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,969,801 · 1
By mechanism
R01$1,969,801 · 1
Top collaborators
- Peter J Allen5 shared
- Christopher L. Wolfgang5 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Samuel Singer$8,089,401
- Danwei Huangfu$13,557,080
- Christopher L. Wolfgang$948,658
- Luisa Escobar Hoyos$5,863,708
- Alice Chia- Chi Wei$2,617,533
Others in their field
Top investigators on “Excision”
- Daniel F Hanley · Johns Hopkins University$44,490,319
- Christina Trahan Cain · Center For Construction Res And Training$44,158,134
- Randall J Bateman · Washington University$41,694,233
- Paul S. Aisen · Cognition Therapeutics, Inc.$34,658,960
- Reisa A. Sperling · Banner Health$34,658,960
- John J. Leconche · Laborers-Agc Education And Training Fund$32,192,185
Research focus
ExcisionEvaluationBiological MarkersEmotionalBlindedEnrollmentCancer PatientCarcinomaAdjuvantDysplasiaClinical Decision-MakingCyst FluidCystic NeoplasmBaseDatabasesData SetDiagnosisDiagnosticCharacteristicsAntibodiesClinical CareDouble-Blind MethodDuct (Organ) StructureFinancial Cost
Grant awards (5)
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas$339,622
R01 · FY2018 · CA
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas$349,513
R01 · FY2017 · CA
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas$349,513
R01 · FY2016 · CA
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas$437,758
R01 · FY2015 · CA
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas$493,395
R01 · FY2014 · CA